Fisher Asset Management LLC decreased its position in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 21.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 850,176 shares of the company’s stock after selling 233,405 shares during the period. Fisher Asset Management LLC owned 1.52% of Azenta worth $55,380,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Norges Bank purchased a new position in shares of Azenta during the 4th quarter worth approximately $140,856,000. Dimensional Fund Advisors LP boosted its position in shares of Azenta by 31.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,231,792 shares of the company’s stock worth $145,382,000 after purchasing an additional 530,408 shares during the period. Fuller & Thaler Asset Management Inc. purchased a new position in shares of Azenta during the 3rd quarter worth approximately $12,250,000. Bank of Nova Scotia purchased a new position in shares of Azenta during the 3rd quarter worth approximately $7,875,000. Finally, Conestoga Capital Advisors LLC boosted its position in shares of Azenta by 13.4% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,291,284 shares of the company’s stock worth $84,114,000 after purchasing an additional 152,090 shares during the period. Hedge funds and other institutional investors own 99.08% of the company’s stock.
Azenta Trading Down 1.6 %
Shares of AZTA opened at $53.91 on Monday. Azenta, Inc. has a twelve month low of $43.37 and a twelve month high of $69.16. The firm’s fifty day simple moving average is $52.67 and its 200-day simple moving average is $59.42. The firm has a market capitalization of $2.91 billion, a price-to-earnings ratio of -19.89 and a beta of 1.51.
Analyst Ratings Changes
Several equities analysts have commented on AZTA shares. Evercore ISI decreased their price target on shares of Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a research report on Thursday, April 4th. Jefferies Financial Group started coverage on shares of Azenta in a research report on Thursday, April 4th. They issued a “hold” rating and a $64.00 price target for the company. Finally, Needham & Company LLC decreased their price target on shares of Azenta from $75.00 to $69.00 and set a “buy” rating for the company in a research report on Thursday, May 9th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $68.40.
View Our Latest Research Report on AZTA
Azenta Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading
- Five stocks we like better than Azenta
- How to Evaluate a Stock Before BuyingÂ
- Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
- Investing in Commodities: What Are They? How to Invest in Them
- Is GoDaddy Stock a Smart Addition to Your Portfolio?
- Stock Sentiment Analysis: How it Works
- Chinese Stocks: Dip to Buy or Time to Avoid?
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.